Another 2024 clinical analysis reported that once GLP-1 receptor agonist treatment was discontinued, participants regained roughly half of the weight they had lost within 26 weeks
This is the playbook for longevity: start with a primary indication, prove safety and efficacy, and then expand to adjacent conditions that share the same root cause
7 Journal of Investigative Dermatology (2000) Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by GHK-CuSimon et al
Urinary tract infections occurred more frequently in female patients
Available from: Mounzer K, Hsu R, Fusco JS, Brunet L, Henegar CE, Vannappagari V, et al
CagriSema# CagriSema is a fixed-ratio combination of two distinct peptide molecules in a single injection device: Cagrilintide : A long-acting amylin analog with a ~7-day half-life achieved through fatty acid acylation